Abstract:Transient receptor potential melastatin 2 (TRPM2), a non-selective cation channel, is involved in many physiological and pathological processes, including temperature sensing, synaptic plasticity regulation, and neurodegenerative diseases. However, the gating mechanism of TRPM2 channel is complex, which hinders its functional research. With the discovery of the Ca2+ binding site in the S2-S3 domain of TRPM2 channel, more and more attention has been drawn to the role of the transmembrane segments in channel gating. In this study, we focused on the D820-F867 segment around the S2 domain, and identified the key residues on it. Functional assays of the deletion mutants displayed that the deletions of D820-W835 and L836-P851 destroyed channel function totally, indicating the importance of these two segments. Sequence alignments on them found three polar and charged residues with high conservation (D820, E829, and R845). D820A, E829A, and R845A which removed the charge and the side chain of the residues were tested by 500 mu M adenosine diphosphate-ribose (ADPR) or 50 mM Ca2+. E829A and R845A affected the characteristic of channel currents, while D820A behaved similarly to WT, indicating the participations of E829 and R845 in channel gating. The charge reversing mutants, E829K and R845D were then constructed and the electrophysiological tests showed that E829A and E829K made the channel lose function. Interestingly, R845A and R845D exhibited an inactivation process when using 500 mu M ADPR, but activated normally by 50 mM Ca2+. Our data suggested that the negative charge at E829 took a vital part in channel activation, and R845 increased the stability of the Ca2+ combination in S2-S3 domain, thus guaranteeing the opening of TRPM2 channel. In summary, our identification of the key residues E829 and R845 in the transmembrane segments of TRPM2. By exploring the gating process of TRPM2 channel, our work helps us better understand the mechanism of TRPM2 as a potential biomarker in neurodegenerative diseases, and provides a new approach for the prediction, diagnosis, and prognosis of neurodegenerative diseases.

TRPM7 activity drives human CD4 T-cell activation and differentiation in a magnesium dependent manner

TRPM2 Is Not Required for T-Cell Activation and Differentiation

Transient receptor potential melastatin 7 and their modulators

TRPM7 Functions in Non-Neuronal and Neuronal Systems: Perspectives on Its Role in the Adult Brain

TRPM7 silencing attenuates Mg2+ influx in cardiac myoblasts, H9c2 cells

TRPM7 Kinase Is Essential for Neutrophil Recruitment and Function via Regulation of Akt/mTOR Signaling

TRPM7 is Regulated by Halides Through Its Kinase Domain.

TRPM7 is critical for short-term synaptic depression by regulating synaptic vesicle endocytosis

Distinct calcium regulation of TRPM7 mechanosensitive channels at plasma membrane microdomains visualized by FRET-based single cell imaging

Exploring therapeutic potential: Targeting TRPM7 in neurodegenerative diseases

TRPA1 Covalent Ligand JT010 Modifies T Lymphocyte Activation

Function and regulation of TRPM7, as well as intracellular magnesium content, are altered in cells expressing ΔF508-CFTR and G551D-CFTR

Stimulating TRPM7 suppresses cancer cell proliferation and metastasis by inhibiting autophagy

Natural and synthetic modulators of SK (K(ca)2) potassium channels inhibit magnesium-dependent activity of the kinase-coupled cation channel TRPM7

Loss of the TRPM4 channel in humans causes immune dysregulation with defective monocyte migration

TRPM7 is Required for Normal Synapse Density, Learning, and Memory at Different Developmental Stages.

TRPM7 is the central gatekeeper of intestinal mineral absorption essential for postnatal survival

The identification of the key residues E829 and R845 involved in transient receptor potential melastatin 2 channel gating

Presence of TRPA1 Modifies CD4+/CD8+ T Lymphocyte Ratio and Activation

Structure of the Mammalian TRPM7, a Magnesium Channel Required During Embryonic Development

TRPM7 Ion Channel: Oncogenic Roles and Therapeutic Potential in Breast Cancer